New York, NY, United States of America

Stephen Ma

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Columbia University. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Ma. Retrieved from https://idiyas.com/inventor/stephen-ma-gv40r9la

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Ma

Introduction

Stephen Ma is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of human heart tissue. With a total of 3 patents, his work is paving the way for advancements in cardiac research and treatment.

Latest Patents

One of Stephen Ma's latest patents is the engineered adult-like human heart tissue, which is a cardiac organoid containing 3-D matter of adult human heart tissue. This innovative approach aims to replicate the complexities of human heart tissue, providing a valuable tool for research and potential therapeutic applications.

Career Highlights

Stephen Ma is affiliated with Columbia University, where he conducts his research and development. His work focuses on creating realistic models of human organs, which can significantly enhance the understanding of various diseases and the testing of new treatments.

Collaborations

Stephen collaborates with notable colleagues such as Gordana Vunjak-Novakovic and Keith Yeager. Their combined expertise contributes to the advancement of research in tissue engineering and regenerative medicine.

Conclusion

Stephen Ma's innovative work in engineered human heart tissue exemplifies the potential of biomedical engineering to transform healthcare. His contributions are vital for future advancements in cardiac research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…